Are there second thoughts about the results of the WHI study?

References

• Rossouw JE, Anderson GL, Prentice R, LaCroix AZ, Kooperberg D, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in health postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Writing Group for the Women's Health Initiative Investigators. JAMA 2002; 288: 321–33
   PubMed Web of Science ®Google Scholar
• Manson JE, Hsia J, Johnson KC, Roussouw JE, Assaf AR, Lasser NL. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523–34
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Thal L, Wallace RB, Ockene JK, Hendrix SL, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2651–62
   PubMed Web of Science ®Google Scholar
• Kaplan B, Yogev Y, Orvieto R, Hirsch M, Fisher M, Rabinerson D. Effect of the WHI study on the attitude of Israeli gynecologists to hormonal therapy during menopause. Clin Exp Obstet Gynecol 2004; 31: 267–68
   PubMedGoogle Scholar
• Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003; 102: 1225–32
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses’ health study. N Engl J Med 1991; 325: 756–62
   PubMed Web of Science ®Google Scholar
• Lindsay R. Estrogen therapy in the prevention and management of osteoporosis. Am J Obstet Gynecol 1987; 156: 1347–51
   PubMed Web of Science ®Google Scholar
• Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Int Med 1992; 117: 1016–37
   PubMed Web of Science ®Google Scholar
• Bush TL. Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy. Eur Heart J 1996; 17: 9–14
   PubMed Web of Science ®Google Scholar
• Col NF, Eckman MH, Karas RH, Pauker SG, Goldberg RJ, Ross EM, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women [see comments]. JAMA 1997; 277: 1140–47
   PubMed Web of Science ®Google Scholar
• Israel Central Bureau of Statistics. Statistical Abstract of Israel, 2003, no. 54. Jerusalem: Israel Central Bureau of Statistics, 2004.
   Google Scholar
• DiSaia PJ, Grosen EA, Kurosaki T, Gildea M, Cowan B, Anton-Culver H. Hormone replacement therapy in breast cancer survivors: a cohort study. Am J Obstet Gynecol 1996; 174: 1494–98
   PubMed Web of Science ®Google Scholar
• Decker DA, Pettinga JE, VanderVelde N, Huang RR, Kestin L, Burdakin JH. Estrogen replacement therapy in breast cancer survivors: a matched-controlled series. Menopause 2003; 10: 277–85
   PubMed Web of Science ®Google Scholar
• Adami S, Rossini M, Zamberlan N, Bertoldo F, Dorizzi R, Lo Cascio V. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women. Maturitas 1993; 17: 191–96
   PubMed Web of Science ®Google Scholar
• Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002; 137: 805–13
   PubMed Web of Science ®Google Scholar
• Haimov-Kochman, R, Hochner-Celnikier, D. Hot flashes-revisited: pharmacological and herbal options for hot flashes management. What does the evidence tell us?. Acta Obst Gynecol Scand. 2005 Oct: 84(10): 972–9.
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson JE, Stampfer MJ. Postmenopausal hormone use and secondary prevention of coronary events in the Nurses’ Health Study. A prospective, observational study. Ann Intern Med 2001; 135: 1–8
   PubMed Web of Science ®Google Scholar
• Karas RH. Current controversies regarding the cardiovascular effects of hormone therapy. Clin Obstet Gynecol 2004; 47: 489–99
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199–208.
   PubMed Web of Science ®Google Scholar
• Spencer C, Crook D, Ross D, Cooper A, Whitehead M, Stevenson J. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels. BJOG 1999; 106: 948–53
   Google Scholar
• Smolders RG, van der Mooren MJ, Teerlink T, Merkus JM, Kroeks MV, Franke HR, et al. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels. Fertil Steril 2003; 79: 261–67
   PubMed Web of Science ®Google Scholar
• Rajkumar C, Kingwell BA, Cameron JD, Waddell T, Mehra R, Christophidis N, et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol 1997; 30: 350–56
   PubMed Web of Science ®Google Scholar
• Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Rajzer M, Jankowski P. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens 2002; 16: 509
   PubMed Web of Science ®Google Scholar
• McCubbin JA, Helfer SG, Switzer FS III, Price TM. Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease. Am Heart J 2002; 143: 711–17
   PubMed Web of Science ®Google Scholar
• Angerer P, Stork S, von Schacky C. Influence of 17beta-oestradiol on blood pressure of postmenopausal women at high vascular risk. J Hypertens 2001; 19: 2135–42
   PubMed Web of Science ®Google Scholar
• Stork S, von Schacky C, Angerer P. The effect of 17beta-estradiol on endothelial and inflammatory markers in post-menopausal women: a randomized, controlled trial. Atherosclerosis 2002; 165: 301–7
   PubMed Web of Science ®Google Scholar
• Guzic-Salobir B, Keber I, Seljeflot I, Arnesen H, Vrabic L. Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women. J Intern Med 2001; 250: 508–15
   PubMed Web of Science ®Google Scholar
• Telci A, Cakatay U, Akhan SE, Bilgin ME, Turfanda A, Sivas A. Postmenopausal hormone replacement therapy use decreases oxidative protein damage. Gynecol Obstet Invest 2002; 54: 88–93
   PubMed Web of Science ®Google Scholar
• Karas RH, Clarkson TB. Considerations in interpreting the cardiovascular effects of hormone replacement therapy observed in the WHI: timing is everything. Menopausal Med 2003; 10: 8–12
   Google Scholar
• Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605–13
   PubMed Web of Science ®Google Scholar
• Byington RP, Furberg CD, Herrington DM, Herd JA, Hunninghake D, Lowery M, et al. Effect of estrogen plus progestin on progression of carotid atherosclerosis in post menopausal women with heart disease: HERS B-mode substudy. Arterioscler Thromb Vasc Biol 2002; 22: 1692–97
   PubMed Web of Science ®Google Scholar
• Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson B, et al. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004; 81: 1498–501
   PubMed Web of Science ®Google Scholar
• Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002; 53: 605–19
   PubMed Web of Science ®Google Scholar
• Mikkola TS, Clarkson TB, Notelovitz M. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?. Ann Med 2004; 36: 402–13
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmeno-pausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–12
   PubMed Web of Science ®Google Scholar
• Herkert O, Kuhl H, Sandow J, Busse R, Schini-Kerth VB. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. Circulation 2001; 104: 2826–31
   PubMed Web of Science ®Google Scholar
• Haynes MP, Li L, Russell KS, Bender JR. Rapid vascular cell responses to estrogen and membrane receptors. Vasc Pharmacol 2002; 38: 99–108
   PubMed Web of Science ®Google Scholar
• Savonenko AV, Markowska AL. The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. Neuroscience 2003; 119: 821–30
   PubMed Web of Science ®Google Scholar
• Carlson MC, Zandi PP, Plassman BL, Tschanz JT, Welsh-Bohmer KA, Steffens DC, et al. Cache County Study Group Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study. Neurology 2001; 57: 2210–16
   PubMed Web of Science ®Google Scholar
• Henderson, VW, Benke, KS, Green, RC, Cupples, LA, Farrer, LA, MIRAGE Study Group. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005; 76: 103–5.
   PubMed Web of Science ®Google Scholar
• Matthews K, Cauley J, Yaffe K, Zmuda JM. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 1999; 47: 518–23
   PubMed Web of Science ®Google Scholar
• The North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004; 11: 11–33.
   PubMed Web of Science ®Google Scholar
• Haimov-Kochman, R, Barak-Glantz, E, Arbel, R, Milwidsky, A, Hochner-Celnikier, D. Exploring the optimal method for discontinuation of HRT-a prospective study. 50th Annual Meeting of the SGI, Washington, DC, 2003.
   Google Scholar